Acasti Pharma (ACST) Q4 2023 Earnings

12FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.54
-0.39
-0.24
-0.09

Details

Expected EPS
N/A
Actual EPS
-0.21
Surprise EPS
-0.21
Surprise Percent
+∞%

Description

Acasti Pharma (ACST) has reported earnings of -0.21 per share for Q4 2023.

0 Comments

Share your thoughts